SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

The Enquirer is investigating readers’ medical bills. For our first story, we talked to Ashley Hack, the mom of a 12-year-old with Type 1 diabetes. Do you have a bill you want us to check out? Email ...

SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...

Cambridge, UK, 25 September 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, has signed ...

We're glad to have the Medtronic CFO, Thierry Pieton, here with us. So welcome. Thank you for joining us. Yes. So look, one of the reasons or some of the reasons I decided to join Medtronic is, first, ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...